These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4082080)

  • 1. Interaction of beta 2-glycoprotein-I with human blood platelets: influence upon the ADP-induced aggregation.
    Nimpf J; Wurm H; Kostner GM
    Thromb Haemost; 1985 Aug; 54(2):397-401. PubMed ID: 4082080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets.
    Nimpf J; Gries A; Wurm H; Kostner GM
    Thromb Haemost; 1985 Dec; 54(4):824-7. PubMed ID: 3003956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human platelets separated from blood by ADP-induced aggregation.
    Mohammad SF; Reddick RL; Mason RG
    Am J Pathol; 1975 Apr; 79(1):81-94. PubMed ID: 1124800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant-free prepared blood platelets and the effect of calcium on their aggregation behaviour.
    Hofmann B; Lösche W; Hofmann J; Till U; Thielmann K
    Artery; 1980; 8(5):437-41. PubMed ID: 6783014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation of washed platelets from non-anticoagulated human blood is not reversible.
    Bowry SK; Müller-Berghaus G
    Thromb Haemost; 1986 Oct; 56(2):172-7. PubMed ID: 3101220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation.
    Nimpf J; Wurm H; Kostner GM
    Atherosclerosis; 1987 Feb; 63(2-3):109-14. PubMed ID: 3827975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
    Arvieux J; Roussel B; Pouzol P; Colomb MG
    Thromb Haemost; 1993 Aug; 70(2):336-41. PubMed ID: 8236145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of extracellular calcium on single platelet activation as measured by whole blood flow cytometry.
    Hu H; Forslund M; Li N
    Thromb Res; 2005; 116(3):241-7. PubMed ID: 15935833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillin-induced dysfunction of platelet membrane glycoproteins.
    Pastakia KB; Terle D; Prodouz KN
    J Lab Clin Med; 1993 Apr; 121(4):546-54. PubMed ID: 8454936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.
    George JN; Lyons RM; Morgan RK
    J Clin Invest; 1980 Jul; 66(1):1-9. PubMed ID: 6772667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional fractionation of platelets: aggregation kinetics and glycoprotein labeling of differing platelet population.
    Haver VM; Gear AR
    Thromb Haemost; 1982 Oct; 48(2):211-6. PubMed ID: 6294898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
    Peerschke EI; Galanakis DK
    J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake.
    Subbarao K; Rucinski B; Rausch MA; Schmid K; Niewiarowski S
    J Clin Invest; 1977 Oct; 60(4):936-43. PubMed ID: 893681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.